Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00874471 · ClinicalTrials.gov registry record

Uveitis Gene-Expression Profiling

A clinical trial, sponsored by Oregon Health and Science University.

Completed
Registry status
280
Enrollment target

NCT00874471 is a clinical trial that has completed, run by Oregon Health and Science University. The registered enrollment target is 280 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00874471 has completed, sponsored by Oregon Health and Science University.

COMPLETED
Registry status
280 participants
Enrollment target

Study Summary

Uveitis is a group of troublesome diseases that collectively represent a cause of blindness comparable to diabetes. Most forms of uveitis are either infectious or immune-mediated. The investigators propose to create a data base on peripheral blood gene expression for patients with 3 of the most important diseases associated with uveitis: ankylosing spondylitis, sarcoidosis, and Behcet's disease. The investigators will quantitatively measure the expression of consistent alteration in peripheral blood from patients with more than 40,000 gene sequences using microarray gene chip technology. This approach is known to detect systemic immune-mediated disease. The investigators will use this data base to: 1. Determine if patients with uveitis and ankylosing spondylitis, sarcoidosis, or Behcet's can be distinguished from a normal population or controls with the same systemic disease but no history of uveitis 2. Determine if the profile of gene expression can distinguish infectious or idiopathic forms of uveitis from patients with spondylitis, sarcoidosis, or Behcet's 3. Determine how this gene profile changes over time as episodic disease such as spondylitis or Behcet's activates or remits 4. Correlate the changes in gene expression with the prognosis of the ocular inflammatory process. The creation of a gene expression data base for patients with uveitis has the potential to clarify the pathogenesis of disease, establish new diagnostic tools, and provide a means for predicting prognosis.

Trial Details

FieldValue
Enrollment Target 280 participants
Start Date 2005-06

What the Registry Record Tells You About NCT00874471

The ClinicalTrials.gov registry entry for NCT00874471 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 280 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Oregon Health and Science University, which has 546 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT00874471 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00874471 about?

NCT00874471 is a clinical study titled "Uveitis Gene-Expression Profiling". Uveitis is a group of troublesome diseases that collectively represent a cause of blindness comparable to diabetes. Most forms of uveitis are either infectious or immune-mediated. The investigators propose to create a data base on peripheral blood gene expression for patients with 3 of the most impo...

What is the current status of trial NCT00874471?

This trial is currently completed. The enrollment target is 280 participants. The study started on 2005-06.

Who is sponsoring clinical trial NCT00874471?

This trial is sponsored by Oregon Health and Science University, which has 546 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.